Company / Free Cash Flow
Voyager Therapeutics, Inc. Free Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
$74.7M
FY2025
5-year range
-$108.8M / $74.7M
FY2021-FY2025
Trend
+597.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Free Cash Flow changed +598% YoY in FY2025, a notable deviation from the 9-year average annual change of +93%.
Based on SEC 10-K filings.
$75M in FY2025.
Improved from -$55M to $75M over the past 2 years.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Voyager Therapeutics, Inc.'s free cash flow has grown for 3 consecutive years.
- In FY2025, free cash flow increased 597.8% year-over-year.
- Lowest free cash flow in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.34 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $74.7M | +597.8% |
| FY2024 | -$15.0M | +72.8% |
| FY2023 | -$55.1M | +49.3% |
| FY2022 | -$108.8M | -365.7% |
| FY2021 | $40.9M | +302.8% |
| FY2020 | -$20.2M | +69.1% |
| FY2019 | -$65.3M | -37.5% |
| FY2018 | -$47.5M | -218.0% |
| FY2017 | $40.3M | +370.2% |
| FY2016 | -$14.9M | -160.9% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026